You now the fool of all the fools... You responded to my negative post on IMUC just 3 days ago! I said that YU blowing out of this shares did not bode well. But I have had enough of you Austin and your incessant #$%$. You are so full of it. It truly warms my heart that you have been battered in this pos. Buy more dummy. Get a home equity loan on your trailer and double up.
I don't want to gloat. I feel bad. This is your hard earned money. But I have to say I have been warning and waring incessantly. Yes, i was short but why wouldn't I be? I knew the science was junk. DCVax Direct makes absolutely NO sense. Time will demonstrate this. It is just something for NWBO mgmt to put on their resume. Brain I think does have a chance but a very small one. The data was cherry picked from the Phase I. I also thought this. But I will get a thumbs down and the morons who pump this will tell you now is the time to buy. The time to buy for a trade is 3.10 with a tight stop at 3 bucks. There are essentially no catalysts unless you think NWBO finally having an updated website is something to celebrate. The only catalyst is a technical one. It might come tomorrow. A wash out day, perhaps a break of 3.10 in some panic on 2 million shares and then you can buy for a bounce and short covering. But as an investment, over and over again you think you guys would simply say, nice call. But you all live in a bubble. Rational, what were you thinking?!!!!
No I think it drifts lower. Read latest post! Why would NWBO go higher when the method of action is now legitimately called into question? Don't be silly. Stop with the delusions. Don't lose your shift. That said, like I asserted, maybe 3.20. But I made a nice profit on the trade. It does not mean I think it goes higher.
I like Rational but there is something called confirmation bias and you people suffer from it. Look I covered in AH so I really don't care. But this IS NOT GOOD NEWS. My goodness look at the stock price of IMUC! Please stop being so delusional. IT IS NOT GOOD NEWS. First, for IMUC there was no clinical benefit on OS which was the endpoint. As for PFS it was 2 months. ICT and DCVax Brain essentially attempt to do the same thing. ICT makes a synthetic antigen found in 50% of the GBM tumors while NWBO takes the actual antigen from the patient. The fact that it DID NOT work for IMUC means the chances are it does not work for NWBO. Moreover, it supports the supposition shorts have made all along that the phase I patients were cherry picked and that is why they got the results they did. In fact is it any surprise that those that pass the 5 and 10 year mark are men in their 30s! STOP with the delusion!!! Now I am the best trader you fools will ever see. So does this mean there is not a trade somewhere? Of course there is. But the trade is not here. You now have tax loss selling that will take over both stocks. IMUC should trade to a buck as they have about .55 cents in cash and they will spin the data. There I would take a shot. NWBO I think has support at 3.20
rational the problem is there was no clinical significance for OS from ICT. I would take a shot as a trade on IMUC at a .85 cents....
You will see.....This therapy does not work. But whatever... I am out of my short. Good luck
This is really not that hard....
I love this stock!!!
For all you short... well done... I like to congratulate myself calling IMUC utter junk just yesterday. Follow the money. Immunotherapy is the great hype.....
This company has just burned so many people
Happy holidays to you. Perhaps we have both made money on NWBO. Not bad. Anyway, I have always said I think Brain has a chance. We won't really know anything for some time. I would go long NWBO and reverse positions on a capitulation down day. Perhaps 2 million shares and a break down to 3.80. Anyway, good luck
So they broke the trend of lower and lower secondary pricing. But the trend of blowing out the stock remains in place. Don't tell me about institutional ownership. Who do you think is selling? The deal was at 4.80. If they liked it at 4.80 why not love it at 4 bucks! They did not take this as an investment. It is a trade. And it is not an investment because there is no faith in the company.
I honestly don't understand people like you. You think that what, you heard Linda first and after the "institutions" get around to listening to the webcast they will start buying? Who do you think was in the audience? Who do you think was selling all day? What did Linda say? You know it's sad when Linda asks attendees to read a Seeking Alpha article. Moreover, the author of that article who has been the one bull spokesperson expressly states omits any comment on the validity of the technology. Strange, n'est ce pas that Larry never has once endorsed DCVAX Direct? He knows it's just a ruse, a distraction. From mice to men. And you all herald the new world of immunotherapy but none of you mention the failures a la Vical, or AGEN or the countless others. Do some more research and you'll understand why the stock is where it is. Don't bet the farm my friend.
Remember when Sabby Mgmt reported a passive 10% stake, they are gone. And something tells me Venture Capital will be gone too next quarter. I think they just got so tired of selling stock at progressively lower prices they got the Fox New Channel to do a little pump for them. The stock ripped and voila they sold stock. Good for them bad for the retail guys who followed. Now the institution blows out the stock and where is Oppenheimer? Talk about a squid pro quo! Oppenheimer gives them the coverage in exchange for the fees and the losers are those that listen to this junk analysis. The deal was done at what 4.80 and now it's hanging on to 4 by a thread and the drop is so fast. They just can't get out fast enough as if they know this is if not a scam an untenable position to hold. Notwithstanding all of this, I do think Brain has a chance. I think results won't be known for over a year though so another raise will come. I also don't think any news on Direct will be meaningful. Yes we know it is safe as all immunotherapy is the question is does it work. Months ago people were insisting that as tumor regression was the endpoint and as the study was unblinded results would be known by the fall. Well we are now in the winter and nothing is said of the results. What does this tell you?
As I trader I like the short side here. I have done well shorting the stock. It is the path of least resistance. I think it goes to the 50 day which I think is 3.88. I would cover there but I could see a capitulation down day coming taking it to 3.50.
Sorry I meant IMUC officers (Yu) blew out all his stock. That was an honest typo. See this is how I see it: CLDX did a secondary early in the year and the stock never hit the deal price ( I think it was priced at 7.50 as I recall and the stock never looked back. NWBO does a deal and I understand the game, they take the stock blow it out and keep the warrants. But institutions whom we must concede know more than us, don't do this as they do with NWBO when they believe in the company and the technology. As I have been repeating DCVax Direct just makes no sense to me. Others have tried direct intra tumoral injection with DC matured and otherwise and failed. Immunotherapy is complex and with time perhaps a partially matured DC along with anti PD1 will work along with other agents and therapy. But alone, I think and I'm pretty sure most scientists would agree, DCVax Direct is just a pipe dream. The company likes to cite the UPenn ovarian cancer study (Powers cited this in today's presentation). Do you know who one of the lead investigators was of that study? It was Dr. Cukos who I think it was of preeminent leaders in the space (he is now with an institute in Switzerland). He did not opt to join NWBO but is a scientific advisor with IMUC. Now I am not pumping IMUC. I have traded the stock but think it is destined for failure. This is the best explanation for why Yu sold all his holdings. Of course the counter argument is that Powers is all in. But I have looked up Toucan Funds' investments and they are all underwater. Cognate is being sued by its former president (Toucan has countersued for stealing trade secrets ... whatever) and I believe they have also been sued for failure to pay rent when they are in Maryland. I point this out only to emphasize that she has a horrid history. NWBO has a horrid history. As much as Austin hates me and I him, I am a student of price action. And the action stinks.
I always liked you. I hope you went long at least a few months back before the hype machine they put in effect in order to do the secondary at a higher price for once breaking the trend of incessantly lower secondary offerings. Well, hey you never know. Short interest is huge. Nobody believes in them or the technology. They may be wrong but I don't think so. DCVax Direct to me borders on stupidity. Brain ... we shall see. Compassionate use has been talked about for years and nothing comes of it. If IMUC reports #$%$ top line results in Feb. they will murder NWBO and the fact that officers in NWBO blew out of all their stock is not very positive. Good luck to you my friend. I just like trading NWBO. I have done well on it a few times. I will cover at the 50 day then maybe go long. But I don't see any reason just yet to cover
Because when she talks it becomes clear that the company is ill managed. Take DCVax Direct. There is 0 chance this works. 0. How do I know. Because study the mechanism of action. Again, it may in the long run advance the science of immunotherapy but this is no holy grail. It is better served as a single site small study undertaken by an academic institution and funded by NIH. NWBO did this because they felt they needed to be more than a hit wonder. But instead, they look negligent and silly. So the study has brought them no more attention. It just is a drain on resources. It is a liability. Thus, instead of having a pipeline they have a liability (DCVax Direct) and one drug under clinical development in a Phase IIII trial. Now Brain is a different story. But their mistake was getting sidetracked. So now the market will discount the liability that was completely unnecessary. Look for 3.80 then I will cover AGAIN and maybe I will go long.....
Laughing stock of the biotech world.... Larry Smith won't even endorse the technology only the financials....